$99.00
In Stock
Indications for use of Hydrea:
– resistant chronic myeloid leukemia;
– locally advanced squamous cell carcinoma of the head and neck (excluding the lips) in combination with chemoradiation therapy.
– melanoma,
– ovarian cancer,
– cervical cancer,
– choriocarcinoma of the uterus,
– erythremia,
– essential thrombocythemia with risk of thromboembolic complications.
Active ingredient: Hydroxycarbamide
Prescription medicine
